310 related articles for article (PubMed ID: 26050202)
1. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
Yang L; Yu L; Chen X; Hu Y; Wang B
Med Sci Monit; 2015 Jun; 21():1656-61. PubMed ID: 26050202
[TBL] [Abstract][Full Text] [Related]
2. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of vincristine toxicity with concomitant fluconazole prophylaxis in children with acute lymphoblastic leukemia.
Teusink AC; Ragucci D; Shatat IF; Kalpatthi R
Pediatr Hematol Oncol; 2012 Feb; 29(1):62-7. PubMed ID: 22304011
[TBL] [Abstract][Full Text] [Related]
4. Severe neurological disorders and refractory aspergillosis in an adolescent treated by vincristine and voriconazole.
Bennis Y; Bodeau S; Lutun A; Gourmel A; Solas C; Quaranta S; Guillaume N; Chouaki T; Lemaire-Hurtel AS; Masmoudi K
J Clin Pharm Ther; 2018 Apr; 43(2):265-268. PubMed ID: 28795412
[TBL] [Abstract][Full Text] [Related]
5. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
[TBL] [Abstract][Full Text] [Related]
6. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
7. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity between voriconazole, fluconazole and itraconazole.
Benjamin Lash D; Jolliff J; Munoz A; Heidari A
J Clin Pharm Ther; 2016 Oct; 41(5):566-7. PubMed ID: 27430151
[TBL] [Abstract][Full Text] [Related]
9. Higher incidence of syndrome of inappropriate antidiuretic hormone secretion during induction chemotherapy of acute lymphoblastic leukemia in indian children.
Seetharam S; Thankamony P; Gopakumar KG; Krishna KMJ
Indian J Cancer; 2019; 56(4):320-324. PubMed ID: 31607700
[TBL] [Abstract][Full Text] [Related]
10. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
[TBL] [Abstract][Full Text] [Related]
11. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
[TBL] [Abstract][Full Text] [Related]
13. Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
Whittle AM; Ali S
Int J Lab Hematol; 2008 Apr; 30(2):173-4. PubMed ID: 18333850
[No Abstract] [Full Text] [Related]
14. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL.
Böhme A; Ganser A; Hoelzer D
Ann Hematol; 1995 Dec; 71(6):311-2. PubMed ID: 8534764
[TBL] [Abstract][Full Text] [Related]
15. Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
Chen L; Li L; Chen W
Clin Pharmacol Drug Dev; 2022 Jun; 11(6):724-733. PubMed ID: 34995400
[TBL] [Abstract][Full Text] [Related]
16. An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States.
Sung AH; Marcella SW; Xie Y
J Med Econ; 2015 May; 18(5):341-8. PubMed ID: 25524741
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole].
Yi XL; Mao Q; Jiang Y; Guo XB; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1627-1630. PubMed ID: 29262887
[TBL] [Abstract][Full Text] [Related]
18. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Jain S; Kapoor G
Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
[No Abstract] [Full Text] [Related]
19. [Severe neurotoxicological reaction by combined treatment with vincristine and fluconazole].
Hellfritzsch M; Lassen P; Nielsen LP
Ugeskr Laeger; 2013 Apr; 175(15):1042-3. PubMed ID: 23582127
[TBL] [Abstract][Full Text] [Related]
20. Syndrome of inappropriate antidiuretic hormone secretion from concomitant use of itraconazole and vindesine.
Zhou H; Li L; Zhou Y; Han Y
J Clin Pharm Ther; 2018 Feb; 43(1):137-140. PubMed ID: 28782144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
